Obsidian Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-03-31 |
|---|---|---|
Revenue | $0 | $0 |
Net Income | -19,633 | -24,986 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -22,013 | -24,424 |
Cash | 26,439 | |
Basic Shares | 61,595 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 |
|---|---|---|
Revenue | $0 | $0 |
Net Income | -100,607 | -83,109 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -90,466 | -75,781 |
Cash | 40,405 | 49,761 |
Basic Shares | 61,595 | 61,595 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$1.19 |
2026-03-31 | -$3.25 |
2025-12-31 | $405.13 |
2025-09-30 | -$2.81 |